Jenny O'Nions

11PUBLICATIONS
38CO-AUTHORS
Haematological tumoursGene and molecular therapyMedical mycologyRespiratory diseasesFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 02, 2025
A phase 1, first-in-human, dose-escalation study of JNJ-74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS.

Emma Searle, Thomas Cluzeau, Jenny O'Nions

|May 23, 2025
Diagnosis and treatment of early T-cell precursor acute lymphoblastic leukaemia.

Ke Xu, Carolyn Maharaj, Eleanor Kaffo

|May 21, 2025
Venetoclax-based non-intensive combinations for relapsed/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme.

Henry Wood, Jenny O'Nions, Wei Yee Chan

|Jan 27, 2025
Diagnosis and treatment of T/myeloid mixed phenotype acute leukaemia (T/M-MPAL).

Ke Xu, Enas Abusalim, Evan Vitsaras

|Jul 08, 2024
CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK.

Priyanka Mehta, Victoria Campbell, Jamie Maddox

|Sep 24, 2023
Managing molecular relapse of acute myeloid leukaemia in early pregnancy: Is a watch and wait approach reasonable?

Dina Mahdi, Jenny O'Nions, Kavita Raj

Pageof 2

Frequent Collaborators

3 joint publications

Andrew Wilson

2 joint publications

Priyanka Mehta

2 joint publications

Rui Zhao

2 joint publications

Rajeev Gupta